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Benign  and  asymptomatic,  the  haemangioma  is  the  most  common  liver  tumour.  In  the
general  population,  the  prevalence  is  between  1—2%  and  20%  [1]. Its  characteristics  are
well  known  in  imaging  (ultrasound,  CT  scan  and  MRI)  and,  when  present,  never  require
a  histological  veriﬁcation.  It  may  have  unusual  aspects  such  as  the  giant  haemangioma
with  central  cystic  degeneration,  the  rapidly  ﬁlling  haemangioma  or  calciﬁcation  [1].  Less
frequent,  hyalinised  haemangiomas  (as  well  as  sclerotic  or  sclerosing  haemangiomas)  may
represent  the  ultimate  stage  in  the  involution  of  haemangiomas.  They  are  most  often
isolated  and  associated  with  a reduction  in  size  [2]. This  article  presents  a  case  of  multiple
haemangiomas  where  the  size  and  radiological  semiology  are  simultaneously  modiﬁed.
Case report
In  2008,  a  47-year-old  woman,  without  any  noteworthy  antecedents  except  for  mood  dis-
orders  treated  with  aripiprazole  (Abilify®)  and  lithium  carbonate  (Teralithe®),  consulted
for  abdominal  pain  without  fever.  The  liver  assessment  was  normal,  the  serologies  for  hep-
atitis  A,  B  and  C  were  negative.  An  ultrasound  examination  revealed  the  presence  of  three
hyperechogenic  focal  hepatic  lesions  with  posterior  reinforcement:  two  lesions  under  4  cm
in  size,  compatible  with  typical  haemangiomas  and  one  10  cm  lesion,  compatible  with  a
giant  haemangioma.
The  MRI  carried  out  immediately  detected  three  formations.  The  semiology  was  typical
of  haemangiomas:  well  limited,  in  T1  hypointensity,  ﬂuid  T2  hyperintensity,  with  enhance-
ment  in  discontinuous  peripheral  lumps  at  arterial  time,  followed  by  progressive  ﬁlling.  A
histological  sample  was  not  taken  due  to  the  presence  of  several  typical  haemangiomas  in
an  asymptomatic  patient.
In  June  2009,  a  second  liver  MRI  without  contrast  injection  was  carried  out  and  revealed
the  three  lesions  in  typical  T2  signal  hyperintensity  (Fig.  1).
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Figure 1. MRI in 2009: T2 sequence: a: lesion A: a giant haemangioma of the right liver, cystic centre, measuring 94 × 104 mm;  b: lesion
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D: a haemangioma of the hepatic dome measuring 32 × 36 mm; c: 
1 × 12 mm (arrow).
In  November  2011,  a  third  liver  MRI  (Fig.  2)  revealed  a
hange  in  the  aspect  of  the  haemangiomas  (Table  1):  reduc-
ion  in  the  size  of  all  of  the  lesions  (up  to  —41%  between
009  and  2011),  modiﬁcation  of  the  T2  signal  intensity  and
isappearance  of  the  typical  enhancement  kinetics  for  the
iant  haemangioma.In  view  of  the  typical  appearance  of  the  haemangiomas  in
he  ﬁrst  MRI  and  since  there  is  no  risk  of  degeneration  of  the
aemangiomas  [1],  a  biopsy  for  aetiological  purposes  was
Table  1  Characteristics  of  three  lesions  in  the  2011  and  2009
Lesion  Size  in  2009
(mm)
Size  in  2011
(mm)
Variation  in  the  large
diameter  2011/2009
(%)
A  104  ×  94  75  ×  72  —28  
B  36  ×  33  25  ×  18  —31  
C  22  ×  12  13  ×  9  —41  
I
t
g C: a small sub-capsular haemangioma of the left liver measuring
ot  taken  in  this  asymptomatic  patient.  After  12  months,
he  patient  is  still  asymptomatic.
iscussion MRI.
st Signal  in  T2  (2011
compared  with  the
2009  MRI)
Enhancement
Very  heterogeneous:
hypo/iso/hypersignal
Periphery:  in  ring
At  the  centre:
heterogeneous,
incomplete,  centripetal
Reduction  in  the
hypersignal
Typical  of  haemanagioma
Hypersignal  stable  Typical  of  haemangioma
n  general,  haemangiomas  do  not  increase  in  size  over
ime  [1,2]. Several  cases  have  been  reported  of  haeman-
iomas  with  a  signiﬁcant  increase  in  size,  generally  within
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Figure 2. MRI in 2011: sequences T2, and T1 after gadolinium injection (portal time): a, b: lesion A: reduction in size (75 × 72 mm),
heterogeneous T2 signal intensity, incomplete and heterogeneous enhancement; c, d: lesion B: reduction in size (25 × 18 mm), weaker T2
signal hyperintensity than in 2009, typical enhancement of a haemangioma, here in peripheral clumps; e, f: lesion C (arrows): reduction in
angio
a
nsize (13 × 9 mm), T2 hyperintensity, typical enhancement of a haem
a  speciﬁc  hormonal  context  (pregnancy,  estroprogestative
contraception)  [1,3].  Among  the  rare  cases  reported  of
a  decrease  in  the  size  of  haemangiomas,  two  of  them
describe  the  reduction  in  the  size  of  a  single  haemangioma
after  treatment  (VEGF  inhibitor  [4],  chemotherapy  [5]),  and
Doyle  reported  the  reduction  in  the  size  of  haemangiomas
l
h
f
hma with homogenisation at portal time (haemangioma not visible).
fter  sclerotic  transformation  without  specifying  if  this  phe-
omenon  is  secondary  or  spontaneous  [2]. Other  benign  liver
esions  are  likely  to  regress  over  time:  nodular  and  focal
yperplasia,  without  the  determination  of  a  formal  cause
or  the  reduction  in  size  in  the  cases  reported  [6,7];  the
aemangioma  may  decrease  or  even  disappear  after  the
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uspension  of  estroprogestative  pill  [8].  As  far  as  we  are
ware,  no  cases  of  spontaneous  and  simultaneous  reduc-
ion  in  the  size  of  several  liver  haemangiomas  have  been
eported.
In  the  case  of  our  patient,  although  the  size  of  the  three
aemangiomas  decreased  only  the  largest,  lesion  A,  presents
 major  change  in  its  signal  in  T2.  It  becomes  very  heteroge-
eous,  and  its  enhancement  looses  its  typical  characteristics
f  haemangioma.  Lesion  C  presents  a  sharp  reduction  of  T2
ignal  intensity  compared  with  the  previous  examination.
esion  B maintains  typical  signal  and  enhancement  kinetics
f  haemangioma.
The  hypothesis  of  a  simultaneous  sclerosis  of  haeman-
iomas  has  been  put  forward.  The  sclerosis  or  hyalinisation
f  haemangiomas  represents  the  ﬁnal  stage  in  the  regres-
ive  phenomena  that  haemangiomas  may  undergo  (necrosis,
hrombosis,  ﬁbrosis,  etc.)  [2].  The  sclerotic  haemangioma
hen  consists  of  an  acellular  eosinophilic  hyaline  substance
ith  rare  sclerotic  vessels  [9].  A  serie  of  ten  sclerotic
aemangiomas  prospectively  monitored  (where  only  two
atients  each  had  two  haemangiomas)  showed  that,  in
eneral,  they  do  not  comply  with  the  typical  imaging  of  hae-
angiomas  as  regards  the  spontaneous  signal  intensity  and
he  enhancement  kinetics  of  the  lesions  [2].  The  monitoring
emonstrates  a  decrease  in  the  size  of  the  lesions  over  time
2].
Although  several  cases  presenting  a  reduction  in  the
ize  of  liver  haemangiomas  have  been  reported,  no  cases
f  simultaneous  and  spontaneous  regression  of  several
iver  haemangiomas  have  been  described  in  the  litera-
ure.  Besides  the  medicinal  causes  already  mentioned,
nother  factor,  whether  endogenous  or  exogenous,  that
ay  affect  or  provoke  this  phenomenon  has  not  been
eported.  In  the  case  of  our  patient,  a  medicinal  or
ormonal  aetiology  was  searched  for  in  the  question-
ng.  Her  treatment  consists  of  aripiprazole  (Abilify®)  and
ithium  carbonate  (Teralithe®).  They  are  not  known  to
ave  any  effect  on  benign  liver  tumours.  Our  patient
oes  not  take  a  hormonal  treatment  and  is  not  clinically
enopaused.  In  addition,  no  cases  of  the  sclerosis  of  hae-
angiomas  have  been  related  to  the  hormonal  status  of
atients.
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onclusion
he  regression  in  the  size  of  haemangiomas  is  rare  and  no
ases  of  the  spontaneous  and  simultaneous  reduction  in  the
ize  of  several  haemangiomas  have  been  described  in  the
ame  patient.  This  exceptional  case  report  indicates  that
actors  are  likely  to  trigger  or  inﬂuence  this  phenomenon.
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